Viatris Inc.
NASDAQ:VTRS
12.93 (USD) • At close November 12, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Viatris Inc. |
Symbool | VTRS |
Munteenheid | USD |
Prijs | 12.93 |
Beurswaarde | 15,433,118,700 |
Dividendpercentage | 4.31% |
52-weken bereik | 9.08 - 13.62 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Scott Andrew Smith |
Website | https://www.viatris.com |
An error occurred while fetching data.
Over Viatris Inc.
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)